Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Gain Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Exercised 825 restricted stock units
@ $0 |
|
07/05/2023 |
4
| Alder Matthias (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Exercised 3,300 restricted stock units
@ $0 |
|
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/22/2022 |
4
| RICHMAN ERIC I (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 329,400 options to buy
@ $3.5, valued at
$1.2M
Granted 54,900 restricted stock units
@ $0 |
|
09/22/2022 |
4
| Islam Khalid (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| Riley Jeffrey Scott (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| Melincoff Gwen A (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| Nicaise Claude (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| HASLER HANS PETER (Director) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 10,500 options to buy
@ $3.5, valued at
$36.8k
|
|
09/22/2022 |
4
| Alder Matthias (COO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Granted 60,900 options to buy
@ $3.5, valued at
$213.2k
Granted 10,200 restricted stock units
@ $0 |
|
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/27/2022 |
4
| RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Bought 2,482 shares
@ $2.58, valued at
$6.4k
|
|
05/23/2022 |
4
| RICHMAN ERIC I (CEO) has filed a Form 4 on Gain Therapeutics, Inc.
Txns:
| Bought 4,000 shares
@ $2.71, valued at
$10.8k
Bought 9,256 shares
@ $2.83, valued at
$26.2k
|
|
12/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|